🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of Tylenol, asserting the companies concealed alleged dangers that the medication created to children's brain development.

This legal action arrives thirty days after President Donald Trump publicized an unproven link between taking acetaminophen - referred to as paracetamol - during pregnancy and autism spectrum disorder in children.

The attorney general is suing Johnson & Johnson, which formerly manufactured the drug, the exclusive pain medication approved for pregnant women, and Kenvue, which presently makes it.

In a statement, he claimed they "betrayed America by gaining financially from discomfort and promoting medication regardless of the dangers."

The manufacturer states there is no credible evidence linking acetaminophen to autism.

"These companies lied for decades, deliberately risking countless individuals to line their pockets," the attorney general, from the Republican party, stated.

The manufacturer commented that it was "very worried by the perpetuation of misinformation on the security of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its website, Kenvue also mentioned it had "regularly reviewed the relevant science and there is lacking reliable evidence that shows a verified association between taking acetaminophen and autism spectrum disorder."

Organizations speaking for physicians and medical practitioners concur.

ACOG has declared acetaminophen - the primary component in acetaminophen - is a restricted selection for expectant mothers to address pain and elevated temperature, which can present serious health risks if left untreated.

"In multiple decades of research on the use of paracetamol in gestation, no reliable research has successfully concluded that the use of paracetamol in any stage of gestation leads to brain development issues in offspring," the group commented.

The lawsuit cites recent announcements from the former administration in claiming the drug is reportedly hazardous.

In recent weeks, Trump caused concern from medical authorities when he advised pregnant women to "resist strongly" not to take Tylenol when sick.

The FDA then issued a notice that doctors should consider limiting the usage of Tylenol, while also stating that "a direct connection" between the drug and autism in young ones has not been established.

Health Secretary Kennedy, who manages the FDA, had vowed in spring to initiate "a massive testing and research effort" that would establish the cause of autism in a limited time.

But specialists advised that identifying a unique factor of autism - thought by researchers to be the consequence of a complicated interplay of inherited and surrounding conditions - would not be simple.

Autism spectrum disorder is a type of lifelong neurodivergence and disability that influences how persons perceive and interact with the environment, and is identified using medical professional evaluations.

In his court filing, Paxton - aligned with the former president who is seeking federal office - claims Kenvue and J&J "deliberately disregarded and attempted to silence the research" around acetaminophen and autism spectrum disorder.

This legal action aims to force the corporations "eliminate any promotional materials" that asserts acetaminophen is safe for expectant mothers.

The court case mirrors the concerns of a assembly of mothers and fathers of children with autism and ADHD who sued the makers of Tylenol in 2022.

Judicial authorities rejected the case, stating investigations from the plaintiffs' authorities was not conclusive.